Sierra Oncology Company Profile, Contacts & Intelligence

Biotechnology ResearchSan Mateo, California, United States10 employees
2 contacts with email or phone data2 with email data
Employees
10
Company source estimate
Reachable Contacts
2
Visible contacts with email or phone data
Contacts With Email
2
2 of 3 visible contacts
Departments
1
Mapped contact coverage

Sierra Oncology Overview

Sierra Oncology is a late-stage biopharmaceutical company on a quest to deliver targeted therapies that treat rare forms of cancer. We harness our deep scientific expertise to identify compounds that target the root cause of disease to advance targeted therapies with assets on the leading edge of cancer biology. Our team takes an evidence-based approach to understand the limitations of current treatments and explore new ways to change the cancer treatment paradigm. Together we are transforming promise into patient impact. Our lead product candidate, momelotinib, is a selective and orally bioavailable JAK1, JAK2 and ACVR1 inhibitor currently under investigation for the treatment of myelofibrosis. Myelofibrosis results from dysregulated JAK-STAT signaling and is characterized by constitutional symptoms, splenomegaly (enlarged spleen) and progressive anemia. Momelotinib is currently under investigation in the MOMENTUM clinical trial, a global, randomized, double-blind Phase 3 study for symptomatic and anemic myelofibrosis patients. Top-line data are anticipated in H1 2022. The U.S. Food & Drug Administration has granted Fast Track designation for momelotinib. Our pipeline also consists of SRA737, a potent, highly selective, orally bioavailable small molecule inhibitor of Checkpoint kinase 1 (Chk1). Promising clinical activity has been observed with SRA737 in combination with low-dose gemcitabine (LDG). Additionally, SRA737 and LDG strongly synergizes with anti-PD(L)1 preclinically, enabling further promising clinical development opportunities. For more information, please visit www.SierraOncology.com.

Headquarters
San Mateo, California, United States
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
Phone Number
Available in AeroLeads
Company Email
Available in AeroLeads

Sierra Oncology Contact Intelligence

See which contact channels and departments are represented in the visible AeroLeads data.

2 contacts with contact data
2 with email data in the visible sample.
1 department represented
Visible contacts with email or phone data are mapped to these departments.
1 company-domain email
Visible contacts using Sierra Oncology's company email domain.
General
1

Sierra Oncology People & Org Chart Preview

Sample people records show job titles and whether email or phone data is available without exposing raw contact details.

Sierra Oncology Workforce Composition

Seniority breakdown across 4 visible profiles.

Individual contributor
4

Compare Similar Companies to Sierra Oncology

Explore companies in related markets and compare their industry and employee estimates.

Company Industry / match Employee estimate Page
Pfizer Pharmaceutical Manufacturing 100.69K View company
GSK Pharmaceutical Manufacturing 90.45K View company
Sanofi Pharmaceutical Manufacturing 88.33K View company
ViiV Healthcare Pharmaceutical Manufacturing 1.88K View company
TESARO, Inc. Pharmaceutical Manufacturing 55 View company
Bellus Health Biotechnology Research 20 View company
Elsie Biotechnologies Biotechnology Research 18 View company
Affinivax Inc. Biotechnology Research 16 View company
Aiolos Bio Biotechnology Research 3 View company
CELLphenomics GmbH Biotechnology Not listed View company